Patent · US Active

Dihydroisoindolones as allosteric modulators of glucokinase

US7928246B2 · kind B2 · utility

0Cited by

1References

1Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

Hiayan Bian · Princeton, US
Joseph Dudash · Fryeburg, US
Mona Patel · Montgomery, US
Philip Rybczynski · Somerville, US
Yongzheng Zhang · Monmouth Junction, US
Mary Pat Beavers · New Hope, US
Maud Urbanski · Flemington, US
Min (Amy) Xiang · Bound Brook, US
Roxanne Zeck · Whitehouse Station, US

Key dates

Filing date	Apr 15, 2009
Grant date	Apr 19, 2011
Priority date	—
Expiry date	Apr 15, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compounds of Formula (I),methods for preparing these compounds, compositions, intermediates and derivatives thereof and for treating glucokinase mediated disorders. More particularly, the compounds of the present invention are glucokinase modulators useful for treating disorders including, but not limited to, type II diabetes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.